Caribou Biosciences Inc. (CRBU)
NASDAQ: CRBUHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CRBU stock chart
Technical analysisKey statistics
All statistics- Market cap
- $66.19M
- EPS (TTM)
- -$1.08
- Dividend yield
- None
- 52-week range
- 0.546 – 3.54
- Day range
- 0.546 – 0.67
- Volume / Avg
- 37.26M / 1.31M
- Beta
- —
- Shares outstanding
- 107.21M
- Next earnings
- Nov 11, 2026
52-week range
CRBU stock today
On Oct 7, CRBU ended the session at $0.6174, shedding $0.5176 (45.60%), versus the S&P 500's 0.22% decline. Volume was 28.4x the average at 37.26M shares, a sign of unusually heavy trading. At this level, CRBU sits near the bottom of its 52-week range of $0.546 to $3.54: 82.5% below the high, set on Nov 3, 2025 and 13.1% above the low.
CRBU is down 61.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 74.6%. Caribou Biosciences has posted a net loss over the last twelve months (EPS of -$1.08), so its P/E ratio is not meaningful. Caribou Biosciences's next earnings report is expected on Nov 11, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Caribou Biosciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 11, 2026
CRBU news
All CRBU newsCaribou Biosciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CSBRChampions Oncology Inc. | 4.88 | -2.59% | $67.92M | vs CRBU |
| KLRSKalaris Therapeutics Inc. | 2.56 | -3.76% | $60.94M | vs CRBU |
| ELOXEloxx Pharmaceuticals Inc. | 14.88 | -1.65% | $60.06M | vs CRBU |
| OKYOOKYO Pharma Limited | 1.41 | -3.42% | $74.00M | vs CRBU |
| INKTMiNK Therapeutics Inc. | 11.42 | -3.47% | $58.28M | vs CRBU |
| LONALeonaBio Inc. | 5.83 | +1.39% | $54.93M | vs CRBU |
| GRMLGreenland Mines Ltd. | 5.83 | -8.62% | $77.81M | vs CRBU |
| BKHABlack Hawk Acquisition Corporation Class A | 13.00 | +5.69% | $54.00M | vs CRBU |
Indexes, lists and sector
Caribou Biosciences stock FAQ
What is Caribou Biosciences's stock price today?
CRBU last traded at $0.6174 as of Oct 7, 4:00 PM EDT, down 45.60% on the day. Prices are delayed at least 15 minutes.
When is Caribou Biosciences's next earnings date?
Caribou Biosciences is expected to report earnings on Wednesday, November 11, 2026.
What is the CRBU 52-week high?
The 52-week high for CRBU is $3.54 and the 52-week low is $0.546. The stock is currently 82.5% below its high.